Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...

The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Mounjaro’s been great,” the comedian said in an Instagram video. “I’m having a really good experience with it and I wanted to ...

Amy Schumer had some positive praise for Mounjaro after a not-so-great experience with Wegovy years prior. "Three years ago, ...

The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...

A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list ...

Fact checked by Nick Blackmer “Microdosing” GLP-1 drugs like Ozempic is gaining attention on social media, but doctors say it ...